Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "22q13.3 deletion syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"22q13.3 deletion syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Conditions: 22q13 Deletion Syndrome;   Phelan-McDermid Syndrome
Interventions: Drug: Insulin-Like Growth Factor-1 (IGF-1);   Drug: Normal saline
2 Recruiting Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Condition: Phelan-McDermid Syndrome
Intervention:

Indicates status has not been verified in more than two years